Is Quest Laborato. overvalued or undervalued?
As of September 15, 2025, Quest Laboratories is fairly valued with a PE ratio of 11.89 and an EV to EBITDA of 10.44, outperforming expensive peers like Sun Pharma and Divi's Lab, despite a year-to-date return of -19.87% compared to the Sensex's 6.02%.
As of 15 September 2025, the valuation grade for Quest Laboratories has moved from attractive to fair. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 11.89, an EV to EBITDA of 10.44, and a ROE of 47.36%. In comparison to its peers, Quest Laboratories has a lower PE ratio than Sun Pharma (33.52) and Divi's Lab (69.55), both of which are considered expensive. Additionally, Quest's EV to EBITDA ratio is more favorable than that of Mankind Pharma (32.69) and Torrent Pharma (31.7), which are also categorized as very expensive. Despite the recent underperformance relative to the Sensex, with a year-to-date return of -19.87% compared to the Sensex's 6.02%, the company's valuation appears justified given its strong operational metrics.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
